Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association, addresses how the role of pharmacists, opportunities, and issues facing community pharmacies internationally compare to the experience of community pharmacists in the United States.
Julie Bullock, VP, global head of clinical pharmacology and translational medicine at Certara, discusses the FDA’s new guidance Project Optimus, which addresses issues relating to dose optimization in clinical trials assessing oncology drugs.
Daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen) was approved in July in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma following their first or subsequent relapse.
In the latest Student Cafe interview series, students from the University of Texas at Austin College of Pharmacy discussed the future of pharmacy after the COVID-19 pandemic.
Nicholas Mathews, co-founder of Stillwater Behavioral Health, discusses how pharmacists can respond to the identification of potentially problematic opioid prescription practices at sober-living facilities.
In the latest Student Cafe interview series, students from the University of Texas at Austin College of Pharmacy discussed the future of pharmacy after the COVID-19 pandemic.
Lisa M. Nijm, MD, JD, educates on Eysuvis, an FDA-approved prescription therapeutic for dry eye disease.
John Beckner, RPh, discusses some of the obstacles to achieving herd immunity for COVID-19.
Antonio Ciaccia, CEO of 46brooklyn Research, discusses his company’s efforts to uncover and understand the structure that underlies US drug pricing distortions.
Sharon Park, PharmD, MEd, BCPS, , associate professor and assistant dean for academic affairs at the Notre Dame of Maryland University School of Pharmacy, discusses career options for pharmacy students outside of the traditional roles of a pharmacist.
Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, assistant professor of pharmacy practice at Loma Linda University School of Pharmacy, discusses the importance of Black pharmacists in creating equitable access to COVID-19 vaccinations.
Experts share final thoughts and advice for clinicians in the community to help optimize treatment success in CLL.
A panel of key stakeholders in the pharmacy field discuss the nature of environmental conditions as a social determinant of health and the potential impact on patient health outcomes, as well as how to best educate patients and colleagues when approaching the subject in the pharmacy.
Octagam 10% is indicated for the treatment of chronic immune thrombocytopenic purpura in adults and dermatomyositis (DM) in adults
The panel discusses the possible prescription treatments for dry eye disease.
With consideration of recent COVID-19 vaccine approval in adolescents, Jennifer Adams, PharmD, EdD, discusses pharmacy’s role in immunizing children of all ages.
The new format being rolled out at Rite Aid stores is designed to center pharmacists and make them easily accessible to patients.
Emerging combination therapies and novel agents being studied as initial therapy for CLL are discussed.
In the latest Student Cafe interview series, students from the University of Texas at Austin College of Pharmacy discussed the future of pharmacy after the COVID-19 pandemic.
In The Legal Prescription series with Ned Milenkovich, we discuss a set of important topics in the pharmacy landscape.
A panel of pharmacists and doctors explain when a patient should seek professional help for dry eye disease.
Study examines whether dapagliflozin is cost-effective when added to standard of care for patients who have heart failure with reduced ejection fraction.
In the latest Student Cafe interview series, students from the University of Texas at Austin College of Pharmacy discussed the future of pharmacy after the COVID-19 pandemic.
Suzanne Soliman, PharmD, BCMAS, discusses how pharmacy can help communities catch up on missed and overdue immunizations resulting from the COVID-19 pandemic.
Monazzah Akbar Sarwar, PharmD, continues the conversation for over-the-counter treatment options for patients with dry eye disease.
In this third video in a series collaboration between Pharmacy Times and USP, Jeanne Sun, PharmD, JD, counsel, legal at USP, discusses information to help pharmacists counsel patients on quality expectations in the pharmacy.
John M. O’Brien, PharmD, MPH, newly appointed President and CEO of the National Pharmaceutical Council, shares his view of what pharmacists contribute to health care.
In The Legal Prescription series with Ned Milenkovich, we discuss a set of important topics in the pharmacy landscape.
Experts provide advice for community pharmacists wanting to explore options, such as Prescription Discount Programs, to help improve their patients’ outcomes.
Experts discuss factors and approaches to consider if choosing between a BTKi-based and BCL2i-based regimen for frontline therapy in CLL.
